|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/13/20 1Life Healthcare Inc. 10-Q 6/30/20 86:10M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.00M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 29K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 29K
12: R1 Document and Entity Information HTML 81K
13: R2 Condensed Consolidated Balance Sheets HTML 138K
14: R3 Condensed Consolidated Balance Sheets HTML 49K
(Parenthetical)
15: R4 Condensed Consolidated Statements of Operations HTML 92K
16: R5 Condensed Consolidated Statements of Comprehensive HTML 50K
Loss
17: R6 Condensed Consolidated Statements of Redeemable HTML 163K
Convertible Preferred Stock and Equity (Deficit)
18: R7 Condensed Consolidated Statements of Redeemable HTML 27K
Convertible Preferred Stock and Equity (Deficit)
(Parenthetical)
19: R8 Condensed Consolidated Statements of Cash Flows HTML 129K
20: R9 Nature of the Business and Basis of Presentation HTML 132K
21: R10 Summary of Significant Accounting Policies HTML 37K
22: R11 Variable Interest Entities HTML 115K
23: R12 Fair Value HTML 118K
24: R13 Revenue Recognition HTML 129K
25: R14 Marketable Securities HTML 86K
26: R15 Property and Equipment, net HTML 66K
27: R16 Leases HTML 88K
28: R17 Debt HTML 73K
29: R18 Redeemable Convertible Preferred Stock HTML 28K
30: R19 Stock-Based Compensation HTML 161K
31: R20 Income Taxes HTML 32K
32: R21 Net Loss Per Share HTML 116K
33: R22 Commitments and Contingencies HTML 33K
34: R23 Related Party Transactions HTML 29K
35: R24 Summary of Significant Accounting Policies HTML 153K
(Policies)
36: R25 Nature of the Business and Basis of Presentation HTML 125K
(Tables)
37: R26 Variable Interest Entities (Tables) HTML 113K
38: R27 Fair Value (Tables) HTML 113K
39: R28 Revenue Recognition (Tables) HTML 127K
40: R29 Marketable Securities (Tables) HTML 84K
41: R30 Property and Equipment, net (Tables) HTML 63K
42: R31 Leases (Tables) HTML 91K
43: R32 Debt (Tables) HTML 63K
44: R33 Stock-Based Compensation (Tables) HTML 158K
45: R34 Net Loss Per Share (Tables) HTML 115K
46: R35 Nature of the Business and Basis of Presentation - HTML 62K
Additional Information (Details)
47: R36 Nature of the Business and Basis of Presentation - HTML 37K
Reconciliation of Cash, Cash Equivalents and
Restricted Cash (Details)
48: R37 Nature of the Business and Basis of Presentation - HTML 39K
Summary of Customers Representing 10% or More of
Accounts Receivables (Details)
49: R38 Nature of the Business and Basis of Presentation - HTML 38K
Summary of Customers Representing 10% or More of
Net Revenue (Details)
50: R39 Variable Interest Entities - Additional HTML 53K
Information (Details)
51: R40 Variable Interest Entities - Summary of HTML 78K
Deconsolidation of Joint Venture (Details)
52: R41 Variable Interest Entities - Assets and HTML 78K
Liabilities Excluding Intercompany Balances are
Eliminated in Consolidated for Joint Ventures
(Details)
53: R42 Fair Value - Schedule of Financial Assets and HTML 48K
Liabilities Measured at Fair Value on Recurring
Basis (Details)
54: R43 Fair Value - Additional Information (Details) HTML 66K
55: R44 Revenue Recognition - Summary of Net Revenue HTML 42K
(Details)
56: R45 Revenue Recognition - Additional Information HTML 53K
(Details)
57: R46 Revenue Recognition - Schedule of Contract Assets HTML 33K
and Deferred Revenue (Details)
58: R47 Revenue Recognition - Schedule of Remaining HTML 35K
Performance Obligation (Details1)
59: R48 Revenue Recognition - Schedule of Remaining HTML 27K
Performance Obligation (Details)
60: R49 Marketable Securities - Summary of Marketable HTML 38K
Securities Classified as Available for Sale
(Details)
61: R50 Marketable Securities - Additional Information HTML 26K
(Details)
62: R51 Property and Equipment, net - Summary of Property HTML 47K
and Equipment (Details)
63: R52 Property and Equipment, net - Additional HTML 41K
Information (Details)
64: R53 Leases - Additional Information (Details) HTML 39K
65: R54 Leases - Components of Operating Lease Costs HTML 31K
(Details)
66: R55 Leases - Supplemental Cash Flow Information HTML 31K
(Details)
67: R56 Leases - Lease Term and Discount Rate (Details) HTML 29K
68: R57 Leases - Future Minimum Lease Payments Under HTML 44K
Non-cancellable Operating Leases (Details)
69: R58 Debt - Additional Information (Details) HTML 101K
70: R59 Debt - Summary of Net Carrying Amount of Liability HTML 38K
Component of Convertible Senior Notes (Details)
71: R60 Debt - Summary of Net Carrying Amount of Equity HTML 33K
Component of Convertible Senior Notes (Details)
72: R61 Debt - Summary of Interest Expense Recognized HTML 38K
Related to Convertible Senior Notes (Details)
73: R62 Redeemable Convertible Preferred Stock - HTML 48K
Additional Information (Details)
74: R63 Stock-Based Compensation - Additional Information HTML 80K
(Detail)
75: R64 Stock-Based Compensation - Summary of Stock Option HTML 72K
Activity (Detail)
76: R65 Stock-Based Compensation - Summary of RSU Activity HTML 42K
(Detail)
77: R66 Stock-Based Compensation - Summary of Stock-based HTML 33K
Compensation Expense (Detail)
78: R67 Income Taxes - Additional Information (Details) HTML 31K
79: R68 Net Loss Per Share - Schedule of Basic and Diluted HTML 52K
Net Loss Per Share (Details)
80: R69 Net Loss Per Share - Schedule of Antidilutive HTML 40K
Securities Excluded from Computation of Earnings
Per Share (Details)
81: R70 Net Loss Per Share - Additional Information HTML 31K
(Details)
82: R71 Commitments and Contingencies - Additional HTML 26K
Information (Details)
83: R72 Related Party Transactions - Additional HTML 30K
Information (Details)
85: XML IDEA XML File -- Filing Summary XML 160K
84: EXCEL IDEA Workbook of Financial Reports XLSX 99K
6: EX-101.INS XBRL Instance -- onem-20200630 XML 2.78M
8: EX-101.CAL XBRL Calculations -- onem-20200630_cal XML 185K
9: EX-101.DEF XBRL Definitions -- onem-20200630_def XML 679K
10: EX-101.LAB XBRL Labels -- onem-20200630_lab XML 1.31M
11: EX-101.PRE XBRL Presentations -- onem-20200630_pre XML 1.07M
7: EX-101.SCH XBRL Schema -- onem-20200630 XSD 181K
86: ZIP XBRL Zipped Folder -- 0001564590-20-040010-xbrl Zip 173K
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of 1Life Healthcare, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: August 13, 2020 |
By: |
|
/s/ Bjorn Thaler |
|
|
|
|
|
|
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/13/20 | None on these Dates | ||
| For Period end: | 6/30/20 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/29/20 1Life Healthcare Inc. 8-K:1,2,3,9 5/26/20 2:991K ActiveDisclosure/FA 2/04/20 1Life Healthcare Inc. 8-K:5,9 2/04/20 2:50K Donnelley … Solutions/FA 1/21/20 1Life Healthcare Inc. S-1/A 16:15M Donnelley … Solutions/FA |